Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Sue Wallace
CEO
swallace@voximetry.com

Message the company or request a 1:1 meeting here

Voximetry is a pre-revenue Healthtech software company entering the commercialization phase. Our product is currently under FDA review and we anticipate FDA market clearance in July 2022. Our core competence is implementing complex medical physics algorithms on high-speed Graphics Processing Units (GPUs). Currently focused on a prostate cancer targeted therapy – radiopharmaceutical therapy – Voximetry provides best-in-class patient-specific treatment plans in this rapidly emerging market (39% CAGR).

Pitch Video

Slide Deck